Cingulate CFO Louis G. Van Horn Retiring >CING
By Dean Seal The chief financial officer of Cingulate retired this week amid an exodus of officers and board members. The clinical stage biopharmaceutical...
Source: marketwatch.com
Stay updated with breaking news from Shane Schaffer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Dean Seal The chief financial officer of Cingulate retired this week amid an exodus of officers and board members. The clinical stage biopharmaceutical...
By Dean Seal Shares of Cingulate tumbled to an all-time low after the company disclosed that several officers and directors have departed amid major...
An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).